Margarete
Margarete Brudny-Kloeppel, Berlin DE
Patent application number | Description | Published |
---|---|---|
20080200440 | Progesterone receptor antagonists - The present invention relates to progesterone receptor antagonists of general formula I: | 08-21-2008 |
Margarete Donovang-Kuhlisch, Lohmar DE
Patent application number | Description | Published |
---|---|---|
20150363246 | Application Service Aggregation and Management - A method and system for aggregating services is provided. The method includes receiving and processing a service request. The service request is submitted to a service catalog and dispatched to a data integration and API module. The service request is transmitted to a management module and processed with respect to a plurality of service providers. Inter process communications associated with the service request are managed. Additionally, an account associated with the service request and the plurality of service providers is managed. | 12-17-2015 |
Margarete Focke-Tejkl, Vienna AT
Patent application number | Description | Published |
---|---|---|
20090324501 | Vaccine Carrier - The present invention relates to a hypoallergenic protein consisting of at least one hypoallergenic molecule derived from an allergen, which is fused or conjugated to at least one second non-allergenic protein or fragment thereof. | 12-31-2009 |
20110195153 | Nutritional Formulation Comprising A Cows Milk Peptide Containing Hydrolysate And Or Peptides Derived Thereof For Tolerance Induction - A nutritional formulation or supplement comprising a cow's milk peptide-containing hydrolysate and/or peptide-containing fraction of the hydrolysate and/or one or more peptides derived from a protein present in cow's milk for use in the induction of tolerance in a human subject, wherein said peptides contained in the hydrolysate or fraction of hydrolysate comprise T cell epitope-containing peptides or wherein said one or more peptides are T cell epitope-containing peptides, and wherein said T cell epitope-containing peptides are capable of driving the immune reaction upon intake of the nutritional formulation towards tolerance. | 08-11-2011 |
20140193450 | PEPTIDE CARRIER FUSION PROTEINS AS ALLERGY VACCINES - The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the N- and C-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide. | 07-10-2014 |
20150335735 | PEPTIDE CARRIER FUSION PROTEINS AS ALLERGY VACCINES - The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the N- and C-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide. | 11-26-2015 |
Margarete Focke-Tejkl, Wien AT
Patent application number | Description | Published |
---|---|---|
20120009210 | HYPALLERGENIC MOSAIC ANTIGENS AND METHODS OF MAKING SAME - Hypoallergenic mosaic antigens assembled from naturally-occurring allergens are disclosed herein. Also disclosed are methods of making such hypoallergenic mosaic antigens, particularly those derived from plant allergens such as timothy grass pollen (Phl p 1 and Phl p 2) and birch pollen (Bet v 1). In a particularly preferred embodiment, the method of making the hypoallergenic mosaic antigen involves the steps of (a) cleaving a naturally-occurring allergen into at least two, preferably at least three non-overlapping peptide fragments and (b) recombining the peptide fragments such that the mosaic antigen includes all or substantially all of the amino acids of the original naturally-occurring allergen, though in a different order. | 01-12-2012 |
20120207788 | HYPOALLERGENIC HYBRID POLYPEPTIDES FOR THE TREATMENT OF ALLERGY - The present invention relates to a method for identifying hypoallergenic polypeptides and to a corresponding screening method. The invention further relates to hypoallergenic polypeptides identified by the method of the invention and to the prophylactic and therapeutic use of these polypeptides. | 08-16-2012 |
Margarete Lecrec, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20130090438 | PROCESS FOR PRODUCING HIGH MOLECULAR WEIGHT POLYETHYLENE - In a process for producing polyethylene having a molecular weight of at least 3×10 | 04-11-2013 |
Margarete Schymura, New York, NY US
Patent application number | Description | Published |
---|---|---|
20090064555 | Frame assembly mountable to an object - A picture frame assembly includes a backing plate having a front surface, a rear surface, and a plurality of parallel grooves in one of the surfaces. The material and thickness of the backing plate are chosen so that the backing plate can be plastically deformed about a bending axis parallel to the grooves. At least one frame element, which can be formed integrally with the backing plate, is for provided for retaining a planar picture element against the front surface of the backing plate. A fastener extends from the rear surface for mounting the assembly to any of various objects, such as a tree, flower stem, a candle, a vase, a basket, a gift wrapping device, a container, a column, and furniture. | 03-12-2009 |